Aligos Therapeutics

ALGS

Börsenwert 30,1 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 EcoR1 Capital San Francisco, California	4,78 Mio. $	–	–	–
2	2 Vivo Capital Palo Alto, California	4,29 Mio. $	–	–	–
3	3 HHLR Advisors Grand Cayman, Cayman Islands	2,86 Mio. $	–	–	–
4	4 Versant Venture Management San Francisco, California	2,81 Mio. $	–	–	–
5	BBA 5 Baker Bros. Advisors New York	2,51 Mio. $	–	–	–
6	6 Novo Holdings A/S Hellerup, Denmark	2,36 Mio. $	–	–	–
7	7 Tang Capital Management San Diego, California	1,87 Mio. $	+2,1 Mio. $	+61.908	Neu
8	8 Boxer Capital San Diego, California	1,85 Mio. $	–	–	–
9	9 Adage Capital Partners Boston, Massachusetts	1,78 Mio. $	–	–	–
10	10 Bank of America Charlotte, North Carolina	1,38 Mio. $	-63.146 $	-1.859	-4 %
11	11 Vanguard Group Malvern, Pennsylvania	1,29 Mio. $	-301.769 $	-8.884	-17 %
12	NM 12 Newtyn Management New York	1,16 Mio. $	+1,31 Mio. $	+38.484	Neu
13	13 Renaissance Technologies New York	1,09 Mio. $	+734.755 $	+21.631	+149 %
14	14 Point72 Asset Management Stamford, Connecticut	968.000 $	–	–	–
15	15 Pivotal bioVenture Partners Investment Advisor San Francisco, California	899.000 $	-181.150 $	-5.333	-15 %
16	16 BlackRock New York	636.000 $	-1,46 Mio. $	-43.019	-67 %
17	17 Millennium Management New York	562.000 $	+630.984 $	+18.576	Neu
18	18 Acadian Asset Management Boston, Massachusetts	380.000 $	+188.317 $	+5.544	+79 %
19	19 New York Life Investment Management New York	262.000 $	+294.704 $	+8.676	Neu
20	20 Two Sigma Investments New York	236.000 $	-9.919 $	-292	-4 %
21	21 Geode Capital Management Boston, Massachusetts	230.000 $	-223.304 $	-6.574	-46 %
22	22 Citadel Advisors Miami, Florida	193.000 $	+185.633 $	+5.465	+612 %
23	23 D.E. Shaw & Co New York	187.000 $	+182.203 $	+5.364	+645 %
24	24 HRT Financial New York	165.000 $	+83.119 $	+2.447	+81 %
25	25 Two Sigma Advisers New York	136.000 $	+67.256 $	+1.980	+79 %

Aligos Therapeutics ALGS Börsenwert 30,1 Mio. $

Aligos Therapeutics

ALGS

Börsenwert 30,1 Mio. $